Jump to Navigation
Trends and Sentiments
Comments and Analysis
U.S. Prepping Case Linking North Korea To $81MM New York...
Healthcare Services Group: A Decade Of "Strategic...
no title provided in feed
Tesla's business just got much more complicated (...
Applying To College? Do Something You Love
Music Platform Salute Offers $63,000 Lifeline To Unsigned...
Can Sears Survive? Maybe Not, Company Admits In Financial...
Kim Jong-Un Has Extra $81 Million To Spend On Rockets...
Why is it so hard for Canadians to believe the ‘benign’...
Canada unveils wait-and-see budget amid U.S. policy...
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Stockman On Thursday's Defining Moment:...
Federal budget 2017: From EI and baby bumps to...
EUR/GBP: 1.1563 USD/EUR: 1.0793 JPY/USD: 111.2710
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions